0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Research with immunoactive agents

Phil Gunby
JAMA. 1981;246(3):205-209. doi:10.1001/jama.1981.03320030007006.
Text Size: A A A
Published online

ABSTRACT

Update on thymosin  Medicine is entering an age of immunopharmacology, says Allan L. Goldstein, PhD, codiscoverer of thymosin, a semipurified extract of the thymus gland.Goldstein now is professor and chairman of the Department of Biochemistry, George Washington University Medical Center, Washington, DC. He and the late Abraham White, PhD, isolated thymosin at Albert Einstein College of Medicine, New York, in 1965.Today, according to Goldstein, in addition to trials sponsored by the National Cancer Institute (NCI) at five centers, more than 150 other research teams in the United States and Europe are testing thymosin's effectiveness at stimulating T lymphocyte immune responses in animals and plants with cancer, infectious diseases, and other disorders associated with immune suppression or imbalance (JAMA [MEDICAL NEWS] 1977;237:429-438).So far, Goldstein told an American Cancer Society seminar in Daytona Beach, Fla, two randomized trials have been completed with thymosin fraction 5, which contains a family

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();